{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:25:25Z","timestamp":1791066325911,"version":"4.1.0"},"reference-count":0,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2014.00036","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T10:17:17Z","timestamp":1393323437000},"source":"Crossref","is-referenced-by-count":71,"title":["Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls"],"prefix":"10.3389","volume":"8","author":[{"given":"Jiann Wei","family":"Yeoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan H.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Dayas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014]]},"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T14:27:02Z","timestamp":1424269622000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2014.00036\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3389\/fnins.2014.00036","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}